MEGAN SHAHLAMIAN: Open Payments
NPI 1073264347 · COCOA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 41 payments from 11 companies in 2025. Trend: 2023 $874 · 2024 $1,297 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $238 |
| ABBVIE INC. | 9 | $195 |
| PFIZER INC. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Exact Sciences Corporation | 3 | $62 |
| Lilly USA, LLC | 2 | $42 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| ACADIA Pharmaceuticals Inc | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Amgen Inc. | 1 | $20 |
Products named: Ozempic, VRAYLAR, Cologuard Collection Kit, UBRELVY, QULIPTA, BREZTRI, Wegovy, NEXLETOL.
Industry payments across FL — which companies pay providers there.
